Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Peripheral Neuritis Treatment Market Size Changed, over the years?
The market size for treating peripheral neuritis has seen robust growth in the past few years. A rise from $1.84 billion in 2024 to $1.93 billion in 2025 is projected, indicating a compound annual growth rate (CAGR) of 5.4%. The impressive growth during the previous years is due to factors such as increased spending on healthcare, rise in chronic illnesses, an elevated burden of diseases related to peripheral neuritis, a higher occurrence rate amongst diabetic patients, and the steadily increasing geriatric population.
How Much Will the Peripheral Neuritis Treatment Market Be Worth in 2029?
The market size for treating peripheral neuritis is projected to expand robustly in the forthcoming years, and is predicted to reach a value of $2.36 billion by 2029, representing a compound annual growth rate (CAGR) of 5.0%. This rate of growth throughout the predicted period can be credited to several factors such as the augmentation in treatment alternatives, a mounting aged population, escalating rates of obesity, prevalence of HIV/AIDS, expansion in the generic drug market, and initiatives from the government and health sector. The major tendencies set to outline the forecast period consist of collaborations and associations, technological progress, surge in launches of diabetic peripheral neuritis treatment products, heightened attention on tailored medicine, the invention of non-pharmacological treatments and the incorporation of digital health tools.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21254&type=smp
Which is the Largest Company in the Peripheral Neuritis Treatment Market?
Major companies operating in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.
What Are the Main Market Drivers in the Peripheral Neuritis Treatment Industry?
The increase in diabetes cases is anticipated to boost the expansion of the peripheral neuritis treatment market. Diabetes, a long-term health condition, happens when the body cannot regulate blood sugar or glucose levels correctly. The hike in diabetes cases can be attributed to factors such as inactive lifestyles, poor eating habits, obesity, aging, and genetic predisposition. Peripheral neuritis treatment assists diabetics by easing nerve pain, decreasing inflammation, and improving nerve function, thereby enhancing their living standards and averting complications. As per the American Diabetes Association, a non-profit organization from the U.S., in 2022 about 25.5 million individuals in the U.S. were detected with diabetes, making up 7.6% of the entire population, thereby underscoring the growth of the peripheral neuritis treatment market due to the surge in diabetes cases.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21254&type=smp
How Is the Peripheral Neuritis Treatment Market Segments Structured?
The peripheral neuritis treatment market covered in this report is segmented –
1) By Treatment Type: Pharmacological Therapies, Non Pharmacological Therapies
2) By Drug Class: Anti-Depressants, Anticonvulsants, Local Anesthesia, Analgesics, Steroids, Other Drug Classes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
4) By Application: Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Other Applications
Subsegments:
1) By Pharmacological Therapies: Pain Relievers (Analgesics), Antidepressants, Anticonvulsants, Topical Medications
2) By Non-Pharmacological Therapies: Physical Therapy, Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture, Lifestyle And Dietary Modifications
What Strategic Trends Are Transforming the Peripheral Neuritis Treatment Market?
Key players in the peripheral neuritis treatment market are shifting their attention towards creating novel treatments like magnetic peripheral nerve stimulation (mPNS) to boost nerve repair and alleviate neuropathic discomfort. Magnetic peripheral nerve stimulation (mPNS) is a non-invasive neuromodulation method that employs magnetic fields to excite peripheral nerves, aiding in pain management, nerve repair enhancement, and better motor functionality in conditions like neuropathy and musculoskeletal disorders. For example, Neuralace Medical Inc., a US-based medical equipment manufacturer, announced in January 2024 the launch of Axon Therapy (mPNS) for the treatment of chronic painful diabetic neuropathy (PDN), which received approval from the US-based government agency, the Food and Drug Administration. This therapy offers a quick, pain-free, non-invasive method for relieving pain. Clinical tests reported a 72.3% responder rate on Day 30 and an 81.4% responder rate on Day 90, underlining its efficacy in relieving pain and numbness. This approval symbolizes a significant progression in pain management, providing patients an alternative to conventional treatments without the medication’s side effects.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/peripheral-neuritis-treatment-global-market-report
Which Global Regions Offer the Highest Growth in the Peripheral Neuritis Treatment Market?
North America was the largest region in the peripheral neuritis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21254
This Report Delivers Insight On:
1. How big is the peripheral neuritis treatment market, and how is it changing globally?
2. Who are the major companies in the peripheral neuritis treatment market, and how are they performing?
3. What are the key opportunities and risks in the peripheral neuritis treatment market right now?
4. Which products or customer segments are growing the most in the peripheral neuritis treatment market?
5. What factors are helping or slowing down the growth of the peripheral neuritis treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model